Benzinga | Jan 11, 2022 07:18AM EST

Barclays Maintains Overweight on Cardinal Health, Lowers Price Target to $63

Barclays analyst Steve Valiquette maintains Cardinal Health (NYSE:CAH) with a Overweight and lowers the price target from $65 to $63.